Table 2. The relationship between LL-37, 25(OH)D and exacerbation risk in COPD patients.
Variables | LL-37 |
25(OH)D |
|||
---|---|---|---|---|---|
r | P | r | P | ||
25(OH)D | 0.115 | 0.303 | 1 | ||
Age | 0.154 | 0.162 | 0.039 | 0.725 | |
FEV1%pred | 0.132 | 0.247 | 0.343* | 0.002 | |
FEV1/FVC | 0.036 | 0.756 | 0.317* | 0.005 | |
Exacerbations per year | −0.227 | 0.052 | −0.341* | 0.003 | |
mMRC score | −0.282 | 0.096 | −0.277 | 0.112 |
*, there is correlation between two indexes. 25(OH)D, 25-hydroxy vitamin D; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; mMRC, Modified British Medical Research Council.